Ananda Pharma

Gain a direct line to Ananda Pharma leadership as we continue our journey to bring MRX1 to market.


Why Invest

Home

Aquis Rule 4.14

Corporate Governance

Company and Advisors

Announcements

Broker Coverage

Publications

Directors

New investors

Presentations

Webinars

Updates

News

Ubuntu

Ananda Pharma investor hub

Welcome to the Ananda Developments investor hub.

Whether you're a shareholder, investor, or simply interested in what we're doing at Ananda, we're delighted to have you here on our Hub.

Ananda is dedicated to developing CBD-based medicines to treat complex, chronic inflammatory pain conditions. With 28 million people in the UK alone dealing with chronic pain and the NHS spending over £5 billion annually on musculoskeletal pain, there is a pressing need for better, more effective treatments.

Using our patent-pending MRX1 CBD formulation we are conducting Phase 2 randomised controlled trials into:

We believe in the transformative potential of cannabinoids, supported by a growing body of clinical and real-world evidence. Our commitment is to deliver:

The highest quality cannabinoid medicines, manufactured in the UK to the strictest pharmaceutical standards.

Robust clinical trial evidence through partnerships with world-leading researchers.

Cannabinoid medicines available on the NHS.

Our Hub is the place for our shareholders, investors, stakeholders and everyone interested in the potential of CBD-based medicines  to read our latest updates and announcements, and watch our videos. Have a question or comment? Send it through. We look forward to answering your questions.

To become a shareholder of Ananda, click here to go to IG Brokers to create an account.